FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097286 [Registered on: 12/11/2025] Trial Registered Prospectively
Last Modified On: 12/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Prevalence of Sensory Loss on Face and Extremities among Adults with Different Types of Leprosy in Delhi 
Scientific Title of Study   PREVALENCE OF SENSORY LOSS ON FACE AND EXTREMITIES AMONG ADULTS WITH DIFFERENT TYPES OF LEPROSY IN DELHI:A Cross-Sectional Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Manushri Parmar 
Designation  Student 
Affiliation  Amity University, Uttar Pradesh 
Address  Amity Institute of Health Allied Sciences (AIHAS) F 1 Block, LGF, Sector-125, Noida-201303, India. Sector-125, Amity University NOIDA (UP)-201301, INDIA
Amity Institute of Health Allied Sciences (AIHAS) F 1 Block, LGF, Sector-125, Noida-201303, India. Sector-125, Amity University NOIDA (UP)-201301, INDIA
Gautam Buddha Nagar
UTTAR PRADESH
201301
India 
Phone  09548400083  
Fax  0120-2431870  
Email  manushriparmar10@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ankit Jain 
Designation  Assistant Professor 
Affiliation  Amity University, Uttar Pradesh 
Address  Amity Institute of Health Allied Sciences (AIHAS) F 1 Block, LGF, Sector-125, Noida-201303, India. Sector-125, Amity University NOIDA (UP)-201301, INDIA
Amity Institute of Health Allied Sciences (AIHAS) F 1 Block, LGF, Sector-125, Noida-201303, India. Sector-125, Amity University NOIDA (UP)-201301, INDIA
Gautam Buddha Nagar
UTTAR PRADESH
201301
India 
Phone  09999600611  
Fax  0120-2431870  
Email  ajain@amity.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Ankit Jain 
Designation  Assistant Professor 
Affiliation  Amity University, Uttar Pradesh 
Address  Amity Institute of Health Allied Sciences (AIHAS) F 1 Block, LGF, Sector-125, Noida-201303, India. Sector-125, Amity University NOIDA (UP)-201301, INDIA
Amity Institute of Health Allied Sciences (AIHAS) F 1 Block, LGF, Sector-125, Noida-201303, India. Sector-125, Amity University NOIDA (UP)-201301, INDIA
Gautam Buddha Nagar
UTTAR PRADESH
201301
India 
Phone  09999600611  
Fax  0120-2431870  
Email  ajain@amity.edu  
 
Source of Monetary or Material Support  
Amity Institute of Health Allied Sciences (AIHAS) F 1 Block, LGF, Sector-125, Noida-201303, India. Sector-125, Amity University NOIDA (UP)-201301, INDIA 
 
Primary Sponsor  
Name  Manushri Parmar 
Address  Amity Institute of Health Allied Sciences (AIHAS) F 1 Block, LGF, Sector-125, Noida-201303, India. Sector-125, Amity University NOIDA (UP)-201301, INDIA 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Sheetal Rawat  The Leprosy Mission Hospital  Road Number 69, Nand Nagri, Dilshad Garden, Delhi
East
DELHI 
9389723767
0120-2431870
sheetalrawat14.r@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
NTCC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: A30||Leprosy [Hansens disease],  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1.Leprosy with microbiological or clinical diagnosis.
2.Age 18 or above.
3. Willingness to participate and provide informed consent. 
 
ExclusionCriteria 
Details  1. Patients diagnosed with diabetes.
2. History of recent trauma or sugery on limbs. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Prevalence of sensory loss on face and extremities among adults with different types of leprosy in Delhi.  At Baseline 
 
Secondary Outcome  
Outcome  TimePoints 
1. Prevalence of ulcer site in leprosy.  At baseline 
2.Association between sensory loss & ulcer severity  At baseline. 
 
Target Sample Size   Total Sample Size="300"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   22/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This synopsis outlines a cross-sectional study titled "Prevalence of sensory loss on face and extremities among adults with different types of leprosy in Delhi: A Cross-Sectional Study".
This study aims to determine the prevalence and types of sensory loss affecting the face and extremities among adults with different types of leprosy in Delhi, a region reporting 1,188 leprosy cases in 2023. It will also explore the prevalence and site distribution of ulcers and examine the association between sensory loss and ulcer severity to enhance early detection and preventive rehabilitation strategies.

Methodology includes:
Study Design: A cross-sectional study with a sample size of 300 participants selected through cluster sampling.

Population: Adults aged 18 years and above, clinically or microbiologically diagnosed with leprosy. Individuals with diabetes or a recent history of trauma or surgery to the limbs will be excluded.

Outcome measures: Sensory testing using standardized methods and evaluation using WHO disability grading and Ulcer grading Scale.

Analysis: Data will be analyzed using Microsoft Excel and R software (version 3.6.1). Descriptive statistics will summarize demographic and clinical characteristics, while Chi-square tests and univariate logistic regression will assess the association between sensory loss and ulcer formation.

The findings are expected to provide region-specific data to guide early identification of high-risk patients, contributing to rehabilitation planning, disability prevention, and long-term patient monitoring in leprosy care.
 
Close